Citations (5)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Jo Lambert, Alexander Nast, Frank O. Nestle & Jörg C Prinz. (2015) Practical guidance on immunogenicity to biologic agents used in the treatment of psoriasis: What can be learnt from other diseases?. Journal of Dermatological Treatment 26:6, pages 520-527.
Read now
Read now
Hélène Gilet, Benoit Arnould, Fatoumata Fofana, Pierre Clerson, Jean-Frédéric Colombel, Olivier D’Hondt, Patrick Faure, Hervé Hagège, Maria Nachury, Stéphane Nahon, Gilbert Tucat, Luc Vandromme, Ines Cazala-Telinge & Emmanuel Thibout. (2014) Measuring patients’ satisfaction with their anti-TNF treatment in severe Crohn’s disease: scoring and psychometric validation of the Satisfaction for PAtients in Crohn’s diseasE Questionnaire (SPACE-Q©). Patient Preference and Adherence 8, pages 1671-1681.
Read now
Read now
Tamsin Gledhill & Keith Bodger. (2013) New and emerging treatments for ulcerative colitis: a focus on vedolizumab. Biologics: Targets and Therapy 7, pages 123-130.
Read now
Read now
Saveria Pastore, Valentina Mariani, Daniela Lulli, Emanuela Gubinelli, Desanka Raskovic, Serena Mariani, Andrea Stancato, Chiara de Luca, Alessandra Pecorelli, Giuseppe Valacchi, Alla I. Potapovich, Vladimir A. Kostyuk & Liudmila G. Korkina. (2011) Glutathione peroxidase activity in the blood cells of psoriatic patients correlates with their responsiveness to Efalizumab. Free Radical Research 45:5, pages 585-599.
Read now
Read now
Gérald E Piérard, Claudine Piérard-Franchimont, Grégory Szepetiuk, Philippe Paquet & Pascale Quatresooz. (2010) The therapeutic potential of TNF-α antagonists for skin psoriasis comorbidities. Expert Opinion on Biological Therapy 10:8, pages 1197-1208.
Read now
Read now